Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Clinical trial NCT04541082 · RECRUITING

Trial details

NCT number: NCT04541082
Sponsor: Jazz Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Neoplasms Glioblastoma Gliosarcoma, Adult Anaplastic Oligodendroglioma Anaplastic Astrocytoma Pilocytic Astrocytoma Oligodendroglioma Gliomatosis Cerebri Pleomorphic Xanthoastrocytoma Anaplastic Pleomorphic Xanthoastrocytoma Diffuse Midline Glioma, H3 K27M-Mutant Ependymoma

Start date: 2020-10-26
Primary completion: 2026-07-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.